€ 24.7
Key Takeaways
Risk factor
Limited trading liquidity
Profitability factor
Very strong margins and returns
About
Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics and devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; imaging devices comprising iCare EIDON...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA, ov
Target Price
The average target price of REG1V.HE is 28 and suggests 15% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio
